Welcome to LookChem.com Sign In|Join Free
  • or
Benzenecarboximidamide, 4-amino-N,N-dimethyl- (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

721387-57-1

Post Buying Request

721387-57-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

721387-57-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 721387-57-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,1,3,8 and 7 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 721387-57:
(8*7)+(7*2)+(6*1)+(5*3)+(4*8)+(3*7)+(2*5)+(1*7)=161
161 % 10 = 1
So 721387-57-1 is a valid CAS Registry Number.

721387-57-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-amino-N,N-dimethylbenzenecarboximidamide

1.2 Other means of identification

Product number -
Other names N,N-Dimethyl-p-aminobenzamidin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:721387-57-1 SDS

721387-57-1Downstream Products

721387-57-1Relevant academic research and scientific papers

Betrixaban structural analogue as well as preparation method and application thereof

-

Paragraph 0010; 0028, (2016/10/08)

The invention provides a novel compound for preparation of drugs for treating venous thrombosis diseases, and particularly relates to a betrixaban structural analogue with a formula (I) shown in the following description or a pharmaceutically acceptable salt thereof, as well as a preparation method and application of the betrixaban structural analogue.

UREAS AS FACTOR XA INHIBITORS

-

Page/Page column 90, (2010/11/08)

The present invention is directed to compounds represented by Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.

TETRAHYDROISOQUINOLINES AS FACTOR XA INHIBITORS

-

Page/Page column 36, (2008/06/13)

The present invention is directed to compounds represented by Formula I and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 721387-57-1